Matches in Wikidata for { <http://www.wikidata.org/entity/Q66545684> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66545684 description "clinical trial" @default.
- Q66545684 description "ensayu clínicu" @default.
- Q66545684 description "klinisch onderzoek" @default.
- Q66545684 description "клінічне випробування" @default.
- Q66545684 name "Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas" @default.
- Q66545684 name "Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas" @default.
- Q66545684 type Item @default.
- Q66545684 label "Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas" @default.
- Q66545684 label "Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas" @default.
- Q66545684 prefLabel "Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas" @default.
- Q66545684 prefLabel "Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas" @default.
- Q66545684 P1050 Q66545684-621ED1B6-1B51-44ED-A1EF-6A733C66DCF1 @default.
- Q66545684 P1132 Q66545684-5433B208-21B7-4F6D-BA58-F33BB8C279FD @default.
- Q66545684 P1476 Q66545684-460B1E4F-E787-4381-AC0C-6B97CE8BEB24 @default.
- Q66545684 P17 Q66545684-04147F33-7888-434F-90AC-2ED134CC3FB9 @default.
- Q66545684 P1813 Q66545684-F8FFFD6E-B1DF-4CC5-8BA9-496C24B57B4D @default.
- Q66545684 P2899 Q66545684-8AB95F95-5836-411D-9893-D05A30B87778 @default.
- Q66545684 P3098 Q66545684-F2CD0939-8576-4F66-AE9C-F6C97E7BBE13 @default.
- Q66545684 P31 Q66545684-40B0CD30-509E-4AE2-9830-7253D5E0D118 @default.
- Q66545684 P4135 Q66545684-5C05FB7C-D19E-4AAD-9DD9-CC0BE1329F2E @default.
- Q66545684 P580 Q66545684-B13434F6-50EE-48DB-AD80-DD113D4116AB @default.
- Q66545684 P582 Q66545684-C6581ED6-7B75-49D0-8342-569ED72BBDD4 @default.
- Q66545684 P6099 Q66545684-53A239A1-4B0D-49B6-855A-9782071A5A15 @default.
- Q66545684 P8363 Q66545684-E29D739F-61D0-4363-9486-2966776017B7 @default.
- Q66545684 P1050 Q33525 @default.
- Q66545684 P1132 "+36" @default.
- Q66545684 P1476 "Double-Blind, Dose Escalating, Randomized, Vehicle-Controlled Proof of Concept Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas" @default.
- Q66545684 P17 Q30 @default.
- Q66545684 P1813 "BCC" @default.
- Q66545684 P2899 "+18" @default.
- Q66545684 P3098 "NCT02828111" @default.
- Q66545684 P31 Q30612 @default.
- Q66545684 P4135 "+85" @default.
- Q66545684 P580 "2016-11-11T00:00:00Z" @default.
- Q66545684 P582 "2017-11-09T00:00:00Z" @default.
- Q66545684 P6099 Q42824440 @default.
- Q66545684 P8363 Q78089383 @default.